MENU
+Compare
CVKD
Stock ticker: NASDAQ
AS OF
Jul 21, 02:03 PM (EDT)
Price
$10.87
Change
-$0.42 (-3.72%)
Capitalization
22.2M

CVKD Cadrenal Therapeutics Inc Forecast, Technical & Fundamental Analysis

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy... Show more

CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CVKD with price predictions
Jul 18, 2025

CVKD sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for CVKD moved below the 200-day moving average on June 13, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CVKD as a result. In of 44 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVKD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CVKD entered a downward trend on June 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CVKD's RSI Oscillator exited the oversold zone, of 13 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for CVKD just turned positive on July 03, 2025. Looking at past instances where CVKD's MACD turned positive, the stock continued to rise in of 23 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CVKD advanced for three days, in of 126 cases, the price rose further within the following month. The odds of a continued upward trend are .

CVKD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.632) is normal, around the industry mean (18.143). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). CVKD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (270.975).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CVKD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVKD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CVKD is expected to report earnings to fall 37.93% to -125 cents per share on August 07

Cadrenal Therapeutics Inc CVKD Stock Earnings Reports
Q2'25
Est.
$-1.26
Q4'24
Missed
by $1.88
Q3'24
Missed
by $2.06
Q2'24
Missed
by $2.13
Q1'24
Missed
by $0.03
The last earnings report on March 13 showed earnings per share of -202 cents, missing the estimate of -15 cents. With 11.59K shares outstanding, the current market capitalization sits at 22.20M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATER1.370.02
+1.48%
Aterian
PAYS7.71-0.04
-0.52%
Paysign
BGS4.07-0.06
-1.45%
B&G Foods
ITGR112.49-2.15
-1.88%
Integer Holdings Corp
IR85.55-2.20
-2.51%
Ingersoll Rand

CVKD and Stocks

Correlation & Price change

A.I.dvisor tells us that CVKD and GDTC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and GDTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-4.89%
GDTC - CVKD
31%
Poorly correlated
-0.33%
MNPR - CVKD
29%
Poorly correlated
-1.63%
WHWK - CVKD
25%
Poorly correlated
-2.70%
RNXT - CVKD
25%
Poorly correlated
N/A
ASMB - CVKD
23%
Poorly correlated
-3.21%
More